Company Overview and News
BAMAKO (Reuters) - Mali’s government is negotiating with mining companies to draft a new mining code but will move to implement a new law unilaterally if no compromise is reached, the West African country’s economy minister said on Friday.
BAMAKO, Jan 17 (Reuters) - Industrial gold production in Mali rose to 49.6 tonnes in 2017, up 5 percent from the previous year, a senior Mines Ministry official said on Wednesday.
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
TORONTO, ONTARIO--(Marketwired - Dec. 12, 2017) - African Gold Group, Inc. (TSX VENTURE:AGG) ("AGG" or the "Company") announces that the binding letter of intent with Hummingbird Resources plc ("HUM") announced on September 27, 2017 has terminated and that all further negotiations regarding the execution of a definitive agreement for a strategic investment by HUM and ongoing joint development of the Company's Kobada gold project have ceased.
Hummingbird Resources (OTCPK:HUMRF) disclosed in its Q3 2017 review that it remains on track and budget to deliver first gold from its Yanfolila project in Mali by the end of 2017. It’s very rare for a gold miner to deliver a project without delay and on budget and I think that Hummingbird will be up for a re-rating as a producer if all goes well to first gold pour and start of commercial production.
LONDON, Sept 27 (Reuters) - African Gold Group and Hummingbird Resources on Wednesday said they had conditionally agreed on an $6.4 million deal for Hummingbird to operate the Kobada Gold Project in Mali.
Hummingbird's Yanfolila mine is still on track and expected to achieve "first gold pour" within the next five months.
Volcanic Gold Mines Inc. ("Volcanic") (TSX VENTURE:VG) is pleased to report details of its mapping and prospecting program at its Mandiana Project in Guinea. Recent field activities have focused on a linear zone of artisanal workings 6.3km in length and up to 550m in width at Tadibakourou, at which coarse gold has been recovered from numerous shallow pits and shafts.
One bank cut its target price right at the 2-month low and right before the gold price shot up again.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 13, 2017) - Volcanic Gold Mines Inc. ("Volcanic") (TSX VENTURE:VG) is pleased to report initial results of its exploration drilling campaign at its Mandiana Projects in Guinea. To date, a total of almost 3,000m of reverse-circulation ("RC") and diamond drilling, and over 15,000m of air-core drilling, have been completed at Mandiana and at lands recently optioned from West African Mining Associates SARL ("WAMA").
Paternoster Resources plc (AIM: PRS), an investment company focused on the natural resources sector, is pleased to announce its audited final results for the year ended 31 December 2016.
Hummingbird Resources (AIM: HUM) is pleased to announce that all resolutions were duly passed at its Annual General Meeting held today.
Hummingbird Resources (AIM: HUM) is pleased to announce it has acquired an additional 5% interest and a 1% royalty in the Yanfolila Gold Project in Mali ("Yanfolila" or "the Project") for US$2 million, increasing its stake to 80% ahead of its first gold pour from Yanfolila targeted by the end of 2017.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 8, 2017) - Volcanic Gold Mines Inc. ("Volcanic") (TSX VENTURE:VG) is pleased to report on the progress of exploration drilling at its Mandiana Project ("Mandiana"), as well as at the contiguous lands recently acquired under option from West African Mining Associates SARL ("WAMA") in Guinea. A total of almost 3,000m of reverse-circulation and diamond drilling, and over 6,000m of air-core drilling have now been completed at these projects.
Hummingbird Resources (AIM: HUM) received notification today that Lindine Inc no longer holds a notifiable interest in the Company.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...